Moving from the bench to the business side of biotech

Every year a steady stream of postdocs, research associates and lab managers decide that the experiment they most want to run is on their own career. Some are tired of the grant cycle. Some love science but not pipetting. Some watched a project they cared about stall for reasons that had nothing to do with the data.

Biotech's business functions need people who understand how experiments work and how they fail. But "I have a PhD" is not a job description. Hiring managers want to know which part of your training maps onto their problem. Below are eight role types, written as composite profiles rather than stories about real people. For the wider map of science careers, including roles close to the lab, start with our guide to careers in the life sciences.

What the bench already taught you

Lab work builds habits that business teams find surprisingly hard to hire for:

• Reading primary literature quickly and spotting a missing control.
• Framing a test around one clear question, then accepting an answer you did not want.
• Keeping records someone else can audit. Good notebook practice is closer to regulatory documentation than most scientists realize.
• Defending a messy result in front of a skeptical lab meeting.

What the bench rarely teaches: how money moves through a company, how contracts divide up risk, how to persuade someone who is not a scientist, and how to decide with half the information you would like. Every role below asks you to close some of that gap.

Eight role profiles

Business development: the deal scout

Business development (BD) teams find, evaluate and negotiate partnerships: licensing a molecule in, licensing a platform out, co-development deals, acquisitions. The early stage is usually called search and evaluation. Someone has to read a small company's data package and decide whether the mouse results justify a second meeting. That someone is often a former scientist.

Transfers: critical reading of data, depth in a therapeutic area. To learn: deal structures (upfront payments, milestones, royalties), basic valuation, term sheets. Common first step: a search and evaluation analyst post, or a sideways move inside a company that already knows your work.

Alliance management: the partnership keeper

Once a deal is signed, two organizations with different habits must work together for years. Alliance managers run joint steering committees, track who owes what under the contract and spot friction before it becomes a dispute. The role suits people who were the informal glue of a multi-lab collaboration.

Transfers: coordination, tact, comfort with technical detail from both sides. To learn: contract literacy, governance, when to escalate. The Association of Strategic Alliance Professionals runs certifications (CA-AM, then CSAP), though time inside a real alliance counts for more. Common first step: project or program management.

Market access: the value translator

An approved therapy only helps patients if insurers and health systems agree to pay for it. Market access and health economics and outcomes research (HEOR) teams build that case with cost-effectiveness models, budget impact models, real-world evidence studies and payer dossiers.

Transfers: statistics, study design, careful writing. To learn: health economics, how US payers and agencies abroad decide coverage, modeling in Excel or R. ISPOR, the professional society for HEOR, runs short courses many people start with. Common first step: analyst at an HEOR consultancy, then in-house.

Regulatory affairs: the rule reader

Regulatory professionals plan and assemble the submissions that agencies such as the FDA review, and tell project teams what evidence a product will need. Cell and gene therapy companies especially need people who understand manufacturing (chemistry, manufacturing and controls, or CMC) as well as clinical data.

Transfers: meticulous documentation, scientific writing, knowing how assays are validated. To learn: the main pathways (IND, BLA, NDA), FDA guidance documents, the Common Technical Document. The Regulatory Affairs Professionals Society offers the Regulatory Affairs Certification (RAC), and several universities run graduate certificates in regulatory science. Common first step: regulatory associate or writer, often after time in quality or CMC.

Medical science liaison: the scientist on the road

Medical science liaisons (MSLs) sit in medical affairs, not sales. They hold scientific conversations with physicians and researchers, answer detailed questions about published data and bring field insights back to the company. Many postings ask for a PhD, PharmD or MD.

Transfers: subject expertise, presenting data, staying calm under hard questions. To learn: interpreting clinical trials and the compliance rules on what can be discussed. This is where basic scientists find it hardest to break in, because employers like to see clinical exposure. Time in clinical research helps. Expect heavy travel.

Life science consulting: the fast learner

Strategy firms hire scientists to answer client questions on tight deadlines. Is this market big enough? Which indication should come first? What will a competitor's launch do to our forecast? Projects run for weeks, not years.

Transfers: rapid literature review, structured problem-solving. To learn: case interviews, slides that make one point each, market sizing, a recommendation in one sentence. Common first step: associate through a formal recruiting cycle, several of which are aimed at PhDs and postdocs.

Equity research: the public-market skeptic

Analysts covering biotech stocks, at banks (sell side) or funds (buy side), judge whether a company's trial is likely to succeed and what that means for its value. A scientist who can predict how a clinical design might fail has a real edge. The job means reading filings constantly; our guide to reading a biotech company's filings covers the documents analysts live in, and the SEC's EDGAR search is where they find them.

Transfers: skepticism about data, knowledge of mechanisms and trial design. To learn: financial modeling, accounting basics. In the US, sell-side research analysts generally need FINRA qualification (the Series 86 and 87 exams), sponsored by the employer. The CFA charter is common but not required to start. Common first step: associate on a senior analyst's team.

Technology transfer: the bridge on campus

University technology transfer offices decide which discoveries to patent, find companies to license them and help faculty start companies. In the US, the Bayh-Dole Act of 1980 lets universities own and license inventions from federally funded research, which is why nearly every research university has such an office. The NIH runs its own technology transfer operation too.

Transfers: grasping an invention quickly across many fields, credibility with faculty. To learn: patent basics, license terms, startup formation; AUTM, the association for the field, runs training. Common first step: a fellowship in your own institution's office, often part-time during a postdoc. Of the eight roles, this is usually the easiest to try before leaving the lab.

The eight roles at a glance

How people actually make the move

Informational interviews come first

People who switch well talk to a lot of people before applying anywhere. An informational interview is a 20 to 30 minute conversation with someone already doing the job. You are not asking for a position; you are asking what their week looks like and who else you should meet. Alumni, former lab members now in industry and speakers at local biotech meetups are the easiest to approach. Two questions work well: "What do new hires from the lab usually get wrong?" and "What would make you say yes to a scientist for this role?"

Certificates help as a signal, rarely on their own

A regulatory science certificate, an HEOR course or a finance class shows you have taken the switch seriously and gives you the vocabulary. It does not replace experience. The most useful programs end with a project you can describe in an interview.

The MBA question

An MBA helps most in business development, corporate strategy and some consulting tracks, particularly at large companies. It helps least in regulatory affairs, MSL work and technology transfer, where domain experience counts for more. A full-time program costs tuition plus two years of income, so many people try a cheaper route first, such as an employer-supported part-time program, or a role that gets them in the door.

Build evidence while you are still in the lab

Do a small version of the job. Volunteer with your tech transfer office. Join a student consulting club that does free projects for startups. Write a two-page analysis of a public company's pipeline. Each gives you an interview story and tells you whether you enjoy the work. Our explainer on translational medicine is useful background for nearly every role above.

The trade-offs nobody puts in the job ad

• You stop being the expert in the room on day one, which can sting after years of specialization.
• Your work becomes less visibly yours. A deal or a filing has many authors.
• Pay varies widely by role and region. An entry-level business post can pay less than a senior scientist job in industry.
• Business teams are often among the first cut when money runs short, for example after a small company's lead trial fails.
• Returning to the bench gets harder after a few years away, because techniques move on.
• Many people find the pace and variety energizing, and feel closer to whether a therapy actually reaches patients.

A realistic first month

1. Pick three roles from the list above.
2. Book two informational interviews for each.
3. Rewrite your CV for one of them in terms of outcomes. "Coordinated a 12-person collaboration across three sites" says more to a business reader than a list of techniques.
4. Start one short course or volunteer project that produces something you can show.
5. Cross off the role that sounded best on paper but worst in conversation.

That fifth step is the one people skip. Ruling out a role early, based on what someone doing it told you, saves more time than any certificate.